» Articles » PMID: 35844282

Medical and Surgical Treatment for Medication-Induced Tremor: Case Report and Systematic Review

Overview
Publisher Wiley
Specialty Neurology
Date 2022 Jul 18
PMID 35844282
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To present a case of refractory medication-induced tremor successfully treated with deep brain stimulation (DBS) of the thalamic ventral intermediate nucleus (Vim) and to propose a medical and surgical treatment algorithm based on a systematical review of the literature.

Methods: Patient data were retrospectively collected. A systematic search was performed in PubMed, Embase, and Cochrane Library. Subjective and objective data were pooled for analysis by classifying them into 5 predefined categories(no, minimal, moderate, good, and excellent effects).

Results: The patient presented with lithium-induced bilateral progressive hand tremor lasting 25 years. After DBS, he reported excellent tremor suppression until the last follow-up (36 months after Vim-DBS). For the review, 34 of 140 studies were included and evaluated (178 unique subjects, 31 different treatments). A good-to-excellent tremor suppression (50%-100%) in at least 50% of subjects was achieved using propranolol (12 studies, 50% of 56 subjects), tetrabenazine (5 studies, 51% of 13 subjects), and metoprolol (4 studies, 75% of 8 subjects). The effect of benztropine and diphenhydramine was none or only minimal to moderate (up to 50% improvement; both: 3 studies, 50% of 4 patients). One article reported minimal-to-moderate effectiveness after DBS of the ventral oral posterior nucleus of the thalamus. Methods were highly heterogeneous. All studies scored grade III or IV quality of evidence, which was insufficient for recommendations (level U).

Conclusion: Treatment decision making should be performed on a case-by-case basis considering the low level of evidence, and we propose a practically oriented treatment algorithm. Propranolol, tetrabenazine, and metoprolol might be effective. For selected and refractory cases, DBS might be considered.

Citing Articles

The Application of Deep Brain Stimulation in the Syndrome of Irreversible Lithium-Effectuated Neurotoxicity.

Okar L, Murin P, Prabhune A, Bucholz R, Chand P J Mov Disord. 2024; 18(1):101-102.

PMID: 39622225 PMC: 11824504. DOI: 10.14802/jmd.24209.


MR-guided focused ultrasound thalamotomy for lithium-induced tremor: a case report and literature review.

Gelman K, Melott J, Thakur V, Tarabishy A, Brandt A, Konrad P Front Neurol. 2024; 14:1331241.

PMID: 38362012 PMC: 10867204. DOI: 10.3389/fneur.2023.1331241.

References
1.
Elble R, Comella C, Fahn S, Hallett M, Jankovic J, Juncos J . Reliability of a new scale for essential tremor. Mov Disord. 2012; 27(12):1567-9. PMC: 4157921. DOI: 10.1002/mds.25162. View

2.
Leigh P, Jefferson D, Twomey A, Marsden C . Beta-adrenoreceptor mechanisms in essential tremor; a double-blind placebo controlled trial of metoprolol, sotalol and atenolol. J Neurol Neurosurg Psychiatry. 1983; 46(8):710-5. PMC: 1027523. DOI: 10.1136/jnnp.46.8.710. View

3.
Koller W, Lyons K, Wilkinson S, Troster A, Pahwa R . Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. Mov Disord. 2001; 16(3):464-8. DOI: 10.1002/mds.1089. View

4.
Bergman H, Soares-Weiser K . Anticholinergic medication for antipsychotic-induced tardive dyskinesia. Cochrane Database Syst Rev. 2018; 1:CD000204. PMC: 6491293. DOI: 10.1002/14651858.CD000204.pub2. View

5.
Poldinger W . Therapy of extrapyramidal side effects, with particular reference to persistent dyskinesia and lithium tremor. Int Pharmacopsychiatry. 1978; 13(4):230-3. DOI: 10.1159/000468344. View